Related Experiment Videos
[Surveillance of renal transplantation in children]
1Service de Néphrologie Pédiatrique, Hôpital des Enfants-Malades, Paris.
Insights
Strict medical monitoring is essential for long-term renal transplant success. Regular clinical, biological, radiological, and histopathological assessments detect rejection, complications, and drug side-effects.
Area of Science:
- Nephrology
- Transplantation Medicine
- Medical Monitoring
Background:
- Long-term success of renal transplantation relies on vigilant patient monitoring.
- Early detection of graft rejection, complications, and drug side-effects is crucial.
Purpose of the Study:
- To outline a comprehensive medical monitoring strategy for renal transplant recipients.
- To detail the essential components of post-transplant surveillance.
Main Methods:
- Monitoring includes clinical data (blood pressure, graft palpation).
- Biological data encompasses blood creatinine, urea, urinalysis, and blood count.
- Radiological (ultrasonography) and histopathological (biopsy, cytology) assessments are vital for suspected issues.
Main Results:
- A multi-faceted approach combining clinical, biological, radiological, and pathological data ensures thorough monitoring.
- The frequency of monitoring adjusts over time but remains continuous throughout graft survival.
Conclusions:
- A strict, multi-modal medical surveillance program is indispensable for optimal long-term renal transplant outcomes.
- Continuous monitoring throughout graft survival is key to managing potential post-transplant issues.
Abstract:
A strict medical monitoring is necessary to ensure the long-term success of renal transplantation, in order to detect the occurrence of rejection, of possible complications, and of side-effects of drugs. This monitoring should be based on 1) clinical data, mainly measurement of blood pressure and graft palpation, 2) biological data, basically blood creatinine and urea, detection of proteinuria and of urinary tract infection, and blood count, 3) radiological data, principally graft ultrasonography, which should be done as soon as rejection or local complications are suspected, and 4) histopathological assessment, by fine-needle aspiration allowing cytological study, or, above all, graft biopsy, searching for rejection, cyclosporine nephrotoxicity, or transplant glomerulopathy. The interval between these controls, very short during the first months, can become longer with time, but a medical surveillance must be maintained throughout the graft survival.